1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid has been researched along with Blood Clot in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gui, L; Huang, F; Li, Z; Peng, S; Wang, X; Wang, Y; Wu, J; Zhang, X; Zhao, M; Zhao, S | 1 |
1 other study(ies) available for 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid and Blood Clot
| Article | Year |
|---|---|
Nano-scaled MTCA-KKV: for targeting thrombus, releasing pharmacophores, inhibiting thrombosis and dissolving blood clots in vivo.
Topics: Administration, Oral; Animals; Blood Coagulation; Blood Platelets; Carbolines; Erythrocytes; Humans; Leukocytes; Magnetic Resonance Spectroscopy; Male; Nanoparticles; P-Selectin; Peptides; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared; Thrombosis | 2019 |